Kim D.

Kim D. has a diverse work experience spanning multiple roles and companies.

In 2007, Kim started as a Molecular Biology Intern at Bayhill Therapeutics. In 2010, Kim interned as a Structural Biology Intern at Genentech.

Kim joined Nektar Therapeutics in 2011 as a Quality Assurance Specialist before transitioning to Codexis, Inc. later that year, where they worked as a Research Assistant II Analytical Biochemistry until 2014.

From 2014 to 2021, Kim worked at Pharmacyclics, starting as a Clinical Trial Assistant, then as a Clinical Research Associate I and II.

In 2017, Kim started working at Corcept Therapeutics as a Senior Clinical Research Associate, then moved on to become a Clinical Trial Manager. By 2020, Kim became a Senior Clinical Trial Manager.

In 2021, Kim joined BridgeBio as an Associate Director Clinical Operations, and by 2023, they were promoted to the role of Director Clinical Operations.

Currently, Kim holds the position of Senior Director and Head of Clinical Operations at Arcellx, starting in May 2023.

Kim D. has a bachelor's degree in Biological Sciences with a focus on Molecular and Cellular Biology from California Polytechnic State University-San Luis Obispo. They also have a degree in Clinical Research Conduct and Management from UC Berkeley Extension. In addition to their degrees, Kim D. has obtained certifications in Clinical Operations and Development - GCP (ICH Focus) and Clinical Operations and Development - GCP (Social-Behavioral) from the CITI Program, both in October 2021. No specific start or end years are provided for their education history.